Dorneyville Pharmacy, Allentown, PA

Is Dorneyville Pharmacy registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Dorneyville Pharmacy hold a Pennsylvania pharmacy license?

State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page. The Delaware Division of Professional Regulation also lists nonresident license A9-0002367 for Dorneyville Pharmacy, ALLENTOWN, PA, status Active, as of Nov 10, 2026.

Has Dorneyville Pharmacy had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Jun 22, 2020), 1 untitled letter (Mar 4, 2020) and 1 FMD-145 letter (Jun 22, 2020) for Dorneyville Pharmacy. State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Dorneyville Pharmacy
Location
Allentown, PA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Jun 22, 2020
FDA Data Dashboard inspections
2 inspections: 1 OAI, 1 VAI; 2 published Form 483s
Form 483 text on this page
1 Form 483, 2 observations
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Dorneyville Pharmacy, a 503A facility, with 3 dated actions.

Document
Jun 22, 2020Warning letter close-outWarning Letter Closeout Issued 06/22/2020Not linked by FDA
Jun 22, 2020FMD-145 letterFMD-145 Letter Issued 6/22/2020FDA copy (archived)
Mar 4, 2020Untitled letterUntitled Letter Issued 03/04/2020FDA copy (archived)

An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Dorneyville Pharmacy, Allentown, PA (FEI number 3005231215), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Sep 28, 2018Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30052312151070496
Jan 7, 2016Official Action Indicated (OAI)Drug Quality Assurance (Drugs)3005231215957597

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Sep 28, 2018: 2 observations

Firm on the cover
Dorneyville Pharmacy, 3330 Hamilton Blvd, CODE
FEI number
3005231215
Establishment type on the cover
Allentown, PA 18103-4593 Producer of non-sterile and sterile drugs
FDA district office on the cover
10 Waterview Blvd., 3"' Floor Parsippany, NJ 07054
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.

Observation 1

The final containers/closures used for drug product intended to be sterile were not sterilized.

Specifically,

Finished product containers, closures, product contact beakers, and mixing rods which are treated for sterilization are wrapped in aluminum foil are stored in an ISO 7 room without an established hold time to ensure that these items remain sterile.

This observation is a repeated objectionable condition reported during the last inspection.

Observation 2

You used a non-pharmaceutical grade component in the formulation of a drug product.

Specifically,

a. T he firm fails to use <Redacted B4> during the compounding of non-sterile drug products. For example, Potassium Bromide (VET) Oral 300 mg/mL solution, Buprenorphine 0.3 mg/mL liquid, and Dexamethasone 0.5 mg/mL oral rinse.

b. The firm has not conducted microbiological testing of the <Redacted B4> used in non-sterile production. This has been used as a component during the production of Potassium Bromide (VET) Oral 300 mg/mL solution, Buprenorphine 0.3 mglmL liquid, and Dexamethasone 0.5 mg/mL oral rinse.

Linked 483s whose text is not shown

State board of pharmacy records

State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
A9-0002367Non Resident PharmacyDorneyville PharmacyALLENTOWN, PAActive

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.